| Featured Articles |
| |
Article Title |
Author(s) |
Pages |
|
|
|
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Abstract: A consensus panel from the United States and Europe was convened recently to update and revise the 1997 consensus guidelines for the neuropathologic evaluation of Alzheimer's disease (AD) an...
|
Bradley T. Hyman,
Creighton H. Phelps,
Thomas G. Beach,
Eileen H. Bigio,
Nigel J. Cairns,
Maria C. Carrillo,
Dennis W. Dickson,
Charles Duyckaerts,
Matthew P. Frosch,
Eliezer Masliah,
Suzanne S. Mirra,
Peter T. Nelson,
Julie A. Schneider,
Dietmar Rudolf Thal,
Bill Thies,
John Q. Trojanowski,
Harry V. Vinters,
Thomas J. Montine
et al.
|
1-13
|
|
|
|
Mild cognitive impairment: Disparity of incidence and prevalence estimates
Abstract: Background: The purpose of conducting this study was to identify areas of concordance and sources of variation for the published rates of prevalence and incidence associated with various def...
|
Alex Ward,
H. Michael Arrighi,
Shannon Michels,
Jesse M. Cedarbaum
|
14-21
|
|
|
|
An economic evaluation of early assessment for Alzheimer’s disease in the United Kingdom
21 March 2011
Abstract: Background: Diagnosing and treating patients with Alzheimer’s disease (AD) at an early stage should improve the quality of life of the patient and caregiver. In the United Kingdom, cost-effe...
|
Dennis Getsios,
Steve Blume,
Khajak J. Ishak,
Grant Maclaine,
Luis Hernández
et al.
|
22-30
|
|
|
|
Screening and treatment for Alzheimer's disease: Predicting population-level outcomes
Abstract: Background: Advances in screening and treatment are needed to mitigate increasing prevalence of dementia due to Alzheimer’s disease (DAT). Current proposals to revise Alzheimer’s disease (AD...
|
Nicolas M. Furiak,
Kristin Kahle-Wrobleski,
Christopher Callahan,
Timothy M. Klein,
Robert W. Klein,
Eric R. Siemers
et al.
|
31-38
|
|
|
|
Modeling Alzheimer’s disease progression using the disease system analysis approach
22 July 2011
Abstract: A novel mechanistic model based on a disease system analysis paradigm was developed to explore the role of homeostatic mechanisms involved in Alzheimer’s disease (AD) progression. We used lo...
|
Roberto Gomeni,
Monica Simeoni,
Marina Zvartau-Hind,
Michael C. Irizarry,
Daren Austin,
Michael Gold
et al.
|
39-50
|
|
|
|
Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease
24 October 2011
Abstract: Background: The utility of fluorodeoxyglucose positron emission tomography (FDG-PET) imaging in Alzheimer’s disease (AD) diagnosis has been well established. Recently, measurement of cerebra...
|
Erik S. Musiek,
Yufen Chen,
Marc Korczykowski,
Babak Saboury,
Patricia M. Martinez,
Janet S. Reddin,
Abass Alavi,
Daniel Y. Kimberg,
David A. Wolk,
Per Julin,
Andrew B. Newberg,
Steven E. Arnold,
John A. Detre
et al.
|
51-59
|
|
| Perspectives |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Addressing the Alzheimer's disease crisis through better understanding, treatment, and eventual prevention of associated neuropsychiatric syndromes
This Perspectives article offers a series of recommendations to the implementers of the National Alzheimer’s Project Act (NAPA) under the premise that better treatment and preventive strategies target...
|
Constantine G. Lyketsos,
David S. Miller,
Neuropsychiatric Syndromes Professional Interest Area of the International Society to Advance Alzheimer’s Research and Treatment
|
60-64
|
|
| Review Articles |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative
03 November 2011
Abstract: Background: Numerous studies show that the cerebrospinal fluid biomarkers total tau (T-tau), tau phosphorylated at threonine 181 (P-tau181P), and amyloid-β (1-42) (Aβ1–42) have high diagnost...
|
Hugo Vanderstichele,
Mirko Bibl,
Sebastiaan Engelborghs,
Nathalie Le Bastard,
Piotr Lewczuk,
Jose Luis Molinuevo,
Lucilla Parnetti,
Armand Perret-Liaudet,
Leslie M. Shaw,
Charlotte Teunissen,
Dirk Wouters,
Kaj Blennow
et al.
|
65-73
|
|
|
|
[123I]N-ω-fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl)nortropane single-photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies
24 October 2011
Abstract: Early, accurate diagnosis of dementia with Lewy bodies (DLB), in particular its differentiation from Alzheimer’s disease, is important for optimal management, providing patients/carers with ...
|
Zuzana Walker,
Jeffrey L. Cummings
|
74-83
|
|
| Association Pages |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Alzheimer’s Association Update January 2012
More than 130 scientists from the pharmaceutical industry, academia, the National Institutes of Health, the U.S. Food and Drug Administration, and the European Medicines Agency gathered in Washington,...
|
|
84-85
|
|
| Retraction notice |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Retraction Notice
Genome-wide assessment of copy number variations in early-onset Alzheimer’s disease. Alzheimer’s & Dementia 2011;7:S94
|
|
86
|
|
| Frontmatter |
| |
Article Title |
Author(s) |
Pages |
|
|
|
Contents
|
|
A1-A2
|
|
|
|
Editorial Board
|
|
A3
|
|
|
|
Medical and Scientific Advisory Council
|
|
A4
|
|
|
|
Subscriber information
|
|
A5
|
|
